Timing of anti-inflammatory combination therapy in diabetic cataract surgery

Phase 1

• Conditions: Cataract senilis; Therapeutic area: Diseases [C] - Eye Diseases [C11]

• Registration Number: EUCTR2016-004514-10-FI
• Lead Sponsor: Raimo Tuuminen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-11-30
• Last Update Posted: 18 April 2017

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Age 60-90 years
Fullfills national criteria for cataract surgery
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 84

Exclusion Criteria

active wet AMD /planned anti-VEGF therapy
prior retinal vein/artery occlusiion, retinal detachment, optic neuritis,
vitreous hemorrhage, intraocular surgery.
Myopia magna.
Pregnancy.
Alcohol misuse.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified